Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus

Clin Cardiol. 2012 Dec;35(12):722-9. doi: 10.1002/clc.22032. Epub 2012 Jul 3.

Abstract

Patients with type 2 diabetes mellitus are at 2 to 4 times increased risk of cardiovascular events compared with those without diabetes, both among patients with multiple risk factors only and those with established atherothrombosis. In this review, we provide recommendations for the use of statins and aspirin for the prevention of cardiovascular events in high-risk patients with diabetes mellitus.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aspirin / therapeutic use*
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / complications*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Practice Guidelines as Topic

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Aspirin